As of 2025-03-24, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (193.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.89 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -3392.2%.
The range of the Relative Valuation is (153.69) - (221.81) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 21.3x - 36.5x | 28.9x |
| Forward P/E multiples | 19.1x - 30.8x | 25.0x |
| Fair Price | (153.69) - (221.81) | (193.91) |
| Upside | -2709.3% - -3866.0% | -3392.2% |
| Date | P/E |